Skip to main content
. 2010 Oct 28;6(10):e1001181. doi: 10.1371/journal.pgen.1001181

Table 2. DUX4 mRNA expression in FSHD and control cell lines.

Cell Code Status Haplotypes Cell type A DUX4-fl DUX4-s 3-prime
MB73 FSHD A161(8)B/161C MB X X X
MB183 FSHD A161(5)/B163 MB X O X
MB148 FSHD A161(3)/A161 MB X O X
MB200 FSHD2 A161(14)/B168 MB X XS X
MB216 FSHD A161(6)/A168 MB O O O
MB219 FSHD A161(5)/B168 MB O O O
MB230 contr A161/163A MB O X O
MB196 contr A161/163A MB O X O
MB226 contr A161/A161 MB O X O
MB135 contr A161/B163 MB O XS O
MB73 FSHD A161/161 MT X X XS
MB183 FSHD A161/B163 MT X O X
MB148 FSHD A161/A161 MT X O XS
MB200 FSHD2 A161/B168 MT XS O XS
MB216 FSHD A161/A168 MT X O XS
MB219 FSHD A161/B168 MT X O X
MB230 contr A161/163A MT O X O
MB196 contr A161/163A MT O X O
MB226 contr A161/A161 MT O X O
MB135 contr A161/B163 MT O X O
M83-9 contr A161/168A fibro O XS O
M83-9 contr iPS XS O X
M83-9 contr EB O X O
43-1 FSHD A161(5)/A161 fibro XS O O
43-1 FSHD iPS XS O X
43-1 FSHD EB X O XS
83-6 FSHD A161(7)/B168 fibro XS XS X
83-6 FSHD iPS X O X
83-6 FSHD EB X O XS
A

MB, myoblasts; MT, myotubes; fibro, fibroblasts; iPS, induced pleuripotent stem cells, EB, embryoid bodies.

B

Number of repeats on contracted allele, if known.

C

Assignment of the second 4q allele variant is incomplete.

n.d., not tested; X, product present; XS, product sequenced; O, product absent.